Gyre Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Gyre Therapeutics, Inc. (GYRE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 210.00 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-08
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 210.00K shares, a 77.94% decline year-over-year.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 1.92M shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 302.00K shares, a 55.51% decline year-over-year.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 685.00K shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.85M shares, a 466.16% increase from fiscal 2024.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 680.73K shares, a 18.83% decline from fiscal 2023.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 838.69K shares.
- Gyre Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 210.00K shares 10-Q · filed 2026-05-08 | 2.13M shares derived: sum of 2 quarters · filed 2026-05-08 | 2.43M shares derived: sum of 3 quarters · filed 2026-05-08 | 3.11M shares derived: sum of 4 quarters · filed 2026-05-08 | |||||
| 2025-12-31 | 1.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 2.22M shares derived: sum of 2 quarters · filed 2026-03-13 | 2.90M shares derived: sum of 3 quarters · filed 2026-03-13 | 3.85M shares 10-K · filed 2026-03-13 | |||||
| 2025-09-30 | 302.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 987.00K shares derived: sum of 2 quarters · filed 2025-11-07 | 1.94M shares 10-Q · filed 2025-11-07 | 1.94M shares derived: sum of 4 quarters · filed 2025-11-07 | |||||
| 2025-06-30 | 685.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 1.64M shares 10-Q · filed 2025-08-11 | 1.64M shares derived: sum of 3 quarters · filed 2025-08-11 | 2.32M shares derived: sum of 4 quarters · filed 2025-08-11 | |||||
| 2025-03-31 | 952.00K shares 10-Q · filed 2025-05-09 | 952.00K shares derived: sum of 2 quarters · filed 2025-05-09 | 1.63M shares derived: sum of 3 quarters · filed 2025-05-09 | 1.63M shares derived: sum of 4 quarters · filed 2025-05-09 | |||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 678.87K shares derived: sum of 2 quarters · filed 2025-03-17 | 678.87K shares derived: sum of 3 quarters · filed 2025-03-17 | 680.73K shares 10-K · filed 2025-03-17 | |||||
| 2024-09-30 | 678.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 678.87K shares derived: sum of 2 quarters · filed 2024-11-13 | 680.73K shares 10-Q · filed 2024-11-13 | 1.52M shares derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.87K shares 10-Q · filed 2024-08-13 | 840.55K shares derived: sum of 3 quarters · filed 2024-08-13 | 840.55K shares derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2024-03-31 | 1.87K shares 10-Q · filed 2024-05-13 | 840.55K shares derived: sum of 2 quarters · filed 2024-05-13 | 840.55K shares derived: sum of 3 quarters · filed 2024-11-13 | 840.55K shares derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-12-31 | 838.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 838.69K shares derived: sum of 2 quarters · filed 2024-11-13 | 838.69K shares derived: sum of 3 quarters · filed 2024-11-13 | 838.69K shares 10-K · filed 2024-03-27 | |||||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 0.00 shares 10-Q · filed 2024-11-13 | 14.01M shares 10-Q · filed 2023-10-26 | -10.27M shares derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 0.00 shares 10-Q · filed 2024-08-13 | 14.01M shares 10-Q · filed 2023-08-14 | -10.27M shares derived: sum of 3 quarters · filed 2024-08-13 | -1.31M shares derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-13 | 14.01M shares 10-Q · filed 2023-05-15 | -10.27M shares derived: sum of 2 quarters · filed 2024-05-13 | -1.31M shares derived: sum of 3 quarters · filed 2024-05-13 | -879.20K shares derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -10.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -1.31M shares derived: sum of 2 quarters · filed 2024-03-27 | -879.20K shares derived: sum of 3 quarters · filed 2024-03-27 | 0.00 shares 10-K · filed 2024-03-27 | 10.27M shares 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | 8.96M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 9.39M shares derived: sum of 2 quarters · filed 2022-11-14 | 10.27M shares 10-Q · filed 2022-11-14 | 10.46M shares derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2022-06-30 | 435.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.31M shares 10-Q · filed 2022-08-15 | 1.51M shares derived: sum of 3 quarters · filed 2022-08-15 | 1.65M shares derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2022-03-31 | 879.20K shares 10-Q · filed 2022-05-09 | 1.07M shares derived: sum of 2 quarters · filed 2022-05-09 | 1.21M shares derived: sum of 3 quarters · filed 2022-05-09 | 1.43M shares derived: sum of 4 quarters · filed 2022-05-09 | |||||
| 2021-12-31 | 192.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 335.75K shares derived: sum of 2 quarters · filed 2022-03-31 | 553.63K shares derived: sum of 3 quarters · filed 2022-03-31 | 1.49M shares 10-K · filed 2022-03-31 | |||||
| 2021-09-30 | 143.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 361.63K shares derived: sum of 2 quarters · filed 2021-11-12 | 1.30M shares 10-Q · filed 2021-11-12 | 1.42M shares derived: sum of 4 quarters · filed 2022-03-31 | |||||
| 2021-06-30 | 217.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.16M shares 10-Q · filed 2021-08-05 | 1.28M shares derived: sum of 3 quarters · filed 2022-03-31 | 1.63M shares derived: sum of 4 quarters · filed 2022-03-31 | |||||
| 2021-03-31 | 939.61K shares 10-Q · filed 2021-05-06 | 1.06M shares derived: sum of 2 quarters · filed 2022-03-31 | 1.41M shares derived: sum of 3 quarters · filed 2022-03-31 | 1.56M shares derived: sum of 4 quarters · filed 2022-03-31 | |||||
| 2020-12-31 | 120.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 473.50K shares derived: sum of 2 quarters · filed 2022-03-31 | 621.50K shares derived: sum of 3 quarters · filed 2022-03-31 | 1.09M shares 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | 353.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 501.50K shares derived: sum of 2 quarters · filed 2020-11-05 | 971.25K shares 10-Q · filed 2020-11-05 | 995.65K shares derived: sum of 4 quarters · filed 2021-03-04 | |||||
| 2020-06-30 | 148.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 617.75K shares 10-Q · filed 2020-08-06 | 642.15K shares derived: sum of 3 quarters · filed 2021-03-04 | 673.35K shares derived: sum of 4 quarters · filed 2021-03-04 | |||||
| 2020-03-31 | 469.75K shares 10-Q · filed 2020-05-11 | 494.15K shares derived: sum of 2 quarters · filed 2021-03-04 | 525.35K shares derived: sum of 3 quarters · filed 2021-03-04 | 611.35K shares derived: sum of 4 quarters · filed 2021-03-04 | |||||
| 2019-12-31 | 24.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 55.60K shares derived: sum of 2 quarters · filed 2021-03-04 | 141.60K shares derived: sum of 3 quarters · filed 2021-03-04 | 450.90K shares 10-K · filed 2021-03-04 | |||||
| 2019-09-30 | 31.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 117.20K shares derived: sum of 2 quarters · filed 2019-11-07 | 426.50K shares 10-Q · filed 2019-11-07 | 474.50K shares derived: sum of 4 quarters · filed 2020-02-20 | |||||
| 2019-06-30 | 86.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 395.30K shares 10-Q · filed 2019-08-01 | 443.30K shares derived: sum of 3 quarters · filed 2020-02-20 | 725.15K shares derived: sum of 4 quarters · filed 2020-02-20 | |||||
| 2019-03-31 | 309.30K shares 10-Q · filed 2019-05-02 | 357.30K shares derived: sum of 2 quarters · filed 2020-02-20 | 639.15K shares derived: sum of 3 quarters · filed 2020-02-20 | 693.45K shares derived: sum of 4 quarters · filed 2020-02-20 | |||||
| 2018-12-31 | 48.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 329.85K shares derived: sum of 2 quarters · filed 2020-02-20 | 384.15K shares derived: sum of 3 quarters · filed 2020-02-20 | 612.05K shares 10-K · filed 2020-02-20 | |||||
| 2018-09-30 | 281.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 336.15K shares derived: sum of 2 quarters · filed 2018-11-01 | 564.05K shares 10-Q · filed 2018-11-01 | 614.05K shares derived: sum of 4 quarters · filed 2019-03-08 | |||||
| 2018-06-30 | 54.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 282.20K shares 10-Q · filed 2018-08-02 | 332.20K shares derived: sum of 3 quarters · filed 2019-03-08 | ||||||
| 2018-03-31 | 227.90K shares 10-Q · filed 2018-05-03 | 277.90K shares derived: sum of 2 quarters · filed 2019-03-08 | |||||||
| 2017-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | 742.00K shares 10-K · filed 2019-03-08 | |||||||
| 2017-09-30 | 692.00K shares 10-Q · filed 2017-11-02 | ||||||||
| 2016-12-31 | -177.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -175.79K shares derived: sum of 2 quarters · filed 2018-03-19 | 3.21K shares derived: sum of 3 quarters · filed 2018-03-19 | 14.71K shares 10-K · filed 2018-03-19 | |||||
| 2016-09-30 | 2.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 181.10K shares derived: sum of 2 quarters · filed 2016-11-03 | 192.60K shares 10-Q · filed 2016-11-03 | ||||||
| 2016-06-30 | 179.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 190.50K shares 10-Q · filed 2016-08-04 | |||||||
| 2016-03-31 | 11.50K shares 10-Q · filed 2016-05-05 | ||||||||
| 2015-12-31 | 45.04K shares 10-K · filed 2017-03-08 | 675.59K shares 10-K · filed 2016-03-09 | |||||||
| 2014-12-31 | 12.41K shares 10-K · filed 2016-03-09 | 935.37K shares 10-K · filed 2015-03-16 | |||||||
| 2013-12-31 | 57.31K shares 10-K · filed 2016-03-09 | 926.65K shares 10-K · filed 2014-03-14 | |||||||
| 2012-12-31 | 1.71M shares 10-K · filed 2013-03-15 | ||||||||
| 2012-05-31 | 1.19M shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |